Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The NOVA-NOA Trial A Novel Aromatase Inhibitor, Leflutrozole, for Treatment of Non-Obstructive Azoospermia A Prospective Interventional Study

NCT07571928 is registered in ClinicalTrials.gov with Martin Blomberg Jensen as lead sponsor.

NCT NCT07571928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07571928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The NOVA-NOA Trial A Novel Aromatase Inhibitor, Leflutrozole, for Treatment of Non-Obstructive Azoospermia A Prospective Interventional Study
Lead sponsor
Martin Blomberg Jensen
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
May 1, 2026
Completion date
August 31, 2027
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infertility due to azoospermia, infertility, male